Vistabamate en es it fr

Vistabamate Brand names, Vistabamate Analogs

Vistabamate Brand Names Mixture

  • No information avaliable

Vistabamate Chemical_Formula


Vistabamate RX_link

No information avaliable

Vistabamate fda sheet

Vistabamate msds (material safety sheet)

Vistabamate Synthesis Reference

No information avaliable

Vistabamate Molecular Weight

309.469 g/mol

Vistabamate Melting Point

< 25 oC

Vistabamate H2O Solubility

Soluble as HCl salt

Vistabamate State


Vistabamate LogP


Vistabamate Dosage Forms

Tablets (oral, 1 mg)

Vistabamate Indication

Used for the symptomatic treatment of parkinsonism.

Vistabamate Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Vistabamate Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Vistabamate side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Vistabamate Patient Information

Vistabamate Organisms Affected

Humans and other mammals